DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR NALMEFENE HYDROCHLORIDE
» See Plans and Pricing
All Clinical Trials for Nalmefene Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000437 | Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 4 | 1969-12-31 | The purpose of this study is to determine the effectiveness of naltrexone (Revia) in reducing drinking and smoking in patients with both nicotine and alcohol dependence. Individuals will be randomly assigned to a 12-week trial of a fixed daily dose of either naltrexone (Revia) and nicotine replacement patch or placebos. All individuals will receive weekly coping skills and smoking-cessation behavioral therapy. Followup interviews will be conducted 3 and 6 months after treatment to determine smoking and drinking status and persistence of any dependence symptoms. |
| NCT00000437 | Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) | Completed | The Scripps Research Institute | Phase 4 | 1969-12-31 | The purpose of this study is to determine the effectiveness of naltrexone (Revia) in reducing drinking and smoking in patients with both nicotine and alcohol dependence. Individuals will be randomly assigned to a 12-week trial of a fixed daily dose of either naltrexone (Revia) and nicotine replacement patch or placebos. All individuals will receive weekly coping skills and smoking-cessation behavioral therapy. Followup interviews will be conducted 3 and 6 months after treatment to determine smoking and drinking status and persistence of any dependence symptoms. |
| NCT00000450 | Naltrexone Maintenance Treatment of Alcoholism | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 4 | 1969-12-31 | The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup. |
| NCT00000450 | Naltrexone Maintenance Treatment of Alcoholism | Completed | The Scripps Research Institute | Phase 4 | 1969-12-31 | The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup. |
| NCT00132119 | Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling | Completed | Somaxon Pharmaceuticals | Phase 2/Phase 3 | 2005-08-01 | The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Nalmefene Hydrochloride
Condition Name
Clinical Trial Locations for Nalmefene Hydrochloride
Trials by Country
Clinical Trial Progress for Nalmefene Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Nalmefene Hydrochloride
Sponsor Name
